oxazolidin-2-one has been researched along with cycloserine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (43.48) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 10 (43.48) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Bayne, WF; Gravellese, D; Hwang, SS; Maglietto, SM; Musson, DG | 1 |
| Janda, J | 1 |
| FORTUNI, M; MERENDA, P; MORETTI, E; SEDIARI, F | 1 |
| LA GRUTTA, G; MONACO, P | 1 |
| BENIGNO, P; MONACO, P | 1 |
| SALGARELLO, G | 2 |
| Kirtaeva, OV; Lazareva, IaR; Romanova, EV; Sokolova, GB; Tsybane, AA | 1 |
| Alffenaar, JW; Bolhuis, MS; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS | 1 |
| Bourgoin, S; Hamon, M; Kayser, V; Latrémolière, A | 1 |
| Freeman, JT; Goh, TL; Jones, KL; Towns, CR; Wong, CS | 1 |
| Andries, K; Bantubani, N; De Marez, T; Diacon, AH; Donald, PR; Grobusch, M; Lounis, N; Mahanyele, R; McNeeley, DF; Meyvisch, P; Narasimooloo, R; Patientia, RF; Pym, A; van Heeswijk, R | 1 |
| Davis, JG; Farley, J; Lancaster, J; Odendaal, R; Shean, K; Van der Walt, M | 1 |
| Hwang, TJ; Jafarov, A; Jakubowiak, W; Keshavjee, S; Nunn, P; Wares, DF | 1 |
| HARRIS, DA; PECK, RL; REAGAN, MA; RUGER, M; WALLICK, H; WOLF, FJ; WOODRUFF, HB | 1 |
| CUCKLER, AC; FROST, BM; McCLELLAND, L; SOLOTOROVSKY, M | 1 |
| CONZELMAN, GM | 1 |
| Acres, RG; Ahmed, M; Prince, KC; Wang, F | 1 |
| Alffenaar, JWC; Migliori, GB; Peloquin, CA | 1 |
| Court, R; de Vries, N; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Stewart, A; Wiesner, L | 1 |
| Martins Dos Santos, VAP; Rienksma, RA; Schaap, PJ; Suarez-Diez, M | 1 |
| Becker, P; Keddy, KH; Lancaster, J; Shean, K; van der Walt, ML | 1 |
| Centner, CM; Chirehwa, M; Court, R; de Vries, N; Denti, P; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Wiesner, L | 1 |
1 review(s) available for oxazolidin-2-one and cycloserine
| Article | Year |
|---|---|
Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis.
Topics: Antibiotics, Antitubercular; Central Nervous System Diseases; Cycloserine; Humans; Isoxazoles; Mental Disorders; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2013 |
2 trial(s) available for oxazolidin-2-one and cycloserine
| Article | Year |
|---|---|
[Rezonizat and cycloserine in complex therapy of drug resistant tuberculosis (comparative studies)].
Topics: Adult; Antibiotics, Antitubercular; Cycloserine; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Oxazolidinones; Tuberculosis, Multidrug-Resistant; Young Adult | 2008 |
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.
Topics: Antitubercular Agents; Clarithromycin; Cycloserine; Dapsone; Diarylquinolines; Erythromycin; Female; Humans; Isoxazoles; Male; Ofloxacin; Oxazolidinones; Quinolines; Tuberculosis, Multidrug-Resistant | 2012 |
20 other study(ies) available for oxazolidin-2-one and cycloserine
| Article | Year |
|---|---|
Simultaneous quantification of cycloserine and its prodrug acetylacetonylcycloserine in plasma and urine by high-performance liquid chromatography using ultraviolet absorbance and fluorescence after post-column derivatization.
Topics: Adult; Chromatography, High Pressure Liquid; Cycloserine; Drug Stability; Humans; Kinetics; Male; Oxazolidinones; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 1987 |
[Urovalidin Bracco in the therapy of urinary tract infections in children].
Topics: Anesthetics, Local; Anti-Infective Agents, Urinary; Cycloserine; Drug Combinations; Drug Evaluation; Humans; Isoxazoles; Oxazoles; Oxazolidinones; Phenazopyridine; Pyridines; Urinary Tract Infections | 1973 |
[EEG study of patients of chronic pulmonary tuberculosis during D-4-amino-3-isoxazolidone (cycloserine) therapy].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Dermatologic Agents; Electroencephalography; Isoxazoles; Oxazolidinones; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Analysis of the central actions of L-4-amino-3-isoxazolidone. Electroencephalographic changes in man].
Topics: Cycloserine; Electroencephalography; Isoxazoles; Oxazolidinones | 1961 |
[Analysis of the sedative effect exerted by 1,4-amino-3-isoxazolidone].
Topics: Cycloserine; Hypnotics and Sedatives; Isoxazoles; Oxazolidinones | 1960 |
[Action of the optical isomers of 4-amino-3-isoxazolidone (cycloserine) and of one of the intermediates in its synthesis (isoxazolidone) on the oxidative metabolism of some strains of Escherichia coli].
Topics: Cell Respiration; Cycloserine; Emotions; Escherichia coli; Isoxazoles; Oxazolidinones | 1960 |
[Action of the optical isomers of 4-amino-3-isoxazolidone (cycloserine) and of one of the intermediates in its synthesis (isoxazolidone) on the oxidative metabolism of some strains of Salmonella and Eberthella].
Topics: Cell Respiration; Cycloserine; Isoxazoles; Oxazolidinones; Salmonella; Salmonella paratyphi A; Salmonella typhi; Sprains and Strains | 1960 |
Clarithromycin significantly increases linezolid serum concentrations.
Topics: Acetamides; Adult; Chromatography, Liquid; Clarithromycin; Clofazimine; Cycloserine; Drug Interactions; Humans; Linezolid; Male; Oxazolidinones; Tandem Mass Spectrometry; Tuberculosis, Pulmonary | 2010 |
N-methyl-D-aspartate receptor-mediated modulations of the anti-allodynic effects of 5-HT1B/1D receptor stimulation in a rat model of trigeminal neuropathic pain.
Topics: Analgesics, Non-Narcotic; Animals; Cycloserine; Dihydroergotamine; Disease Models, Animal; Drug Synergism; Excitatory Amino Acid Antagonists; Hyperalgesia; Male; Motor Activity; Oxazolidinones; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sciatica; Serotonin 5-HT1 Receptor Agonists; Trigeminal Neuralgia; Tryptamines | 2011 |
Extensively drug-resistant tuberculosis: New Zealand's first case and the challenges of management in a low-prevalence country.
Topics: Acetamides; Adult; Aminosalicylic Acid; Antitubercular Agents; Aza Compounds; Cycloserine; Emigrants and Immigrants; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Imipenem; Linezolid; Lymph Nodes; Male; Moxifloxacin; Myanmar; New Zealand; Oxazolidinones; Quinolines; Radiography | 2011 |
Serious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients.
Topics: Adult; Antitubercular Agents; Coinfection; Cycloserine; Drug Resistance, Multiple, Bacterial; Female; Hearing Loss; HIV Infections; Humans; Isoxazoles; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Prospective Studies; Psychoses, Substance-Induced; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Discovery, development, and antimicrobial properties of D-4-amino-3-isoxazolidone (oxamycin), a new antibiotic produced by Streptomyces garyphalus n. sp.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cycloserine; Dermatologic Agents; Isoxazoles; Oxazolidinones; Streptomyces | 1955 |
The antimicrobial evaluation of oxamycin (D-4-amino-3-isoxazolidone), a new broad-spectrum antibiotic.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cycloserine; Dermatologic Agents; Humans; Isoxazoles; Oxazolidinones | 1955 |
Excretion and metabolism of D-4-amino-3-isoxazolidone (cycloserine) by the Rhesus monkey.
Topics: Animals; Anti-Bacterial Agents; Biological Transport; Body Fluids; Cycloserine; Isoxazoles; Macaca mulatta; Oxazolidinones; Urine | 1955 |
Structures of cycloserine and 2-oxazolidinone probed by X-ray photoelectron spectroscopy: theory and experiment.
Topics: Cycloserine; Molecular Structure; Oxazolidinones; Photoelectron Spectroscopy; Quantum Theory | 2014 |
Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone.
Topics: Antitubercular Agents; Cycloserine; Humans; Isoxazoles; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis.
Topics: Adult; Antitubercular Agents; Area Under Curve; Chromatography, Liquid; Cycloserine; Female; HIV Infections; Humans; Isoxazoles; Male; Middle Aged; Oxazolidinones; Prospective Studies; Regression Analysis; South Africa; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2018 |
Modeling Host-Pathogen Interaction to Elucidate the Metabolic Drug Response of Intracellular
Topics: Adenosine Triphosphatases; Amides; Amino Acids; Antitubercular Agents; Cycloserine; Diarylquinolines; Drug Tolerance; Ethambutol; Ethionamide; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Host-Pathogen Interactions; Humans; Isoniazid; Isoxazoles; Metabolic Networks and Pathways; Models, Biological; Mycobacterium bovis; Mycobacterium tuberculosis; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis | 2019 |
Treatment Outcomes and Adverse Drug Effects of Ethambutol, Cycloserine, and Terizidone for the Treatment of Multidrug-Resistant Tuberculosis in South Africa.
Topics: Adult; Antitubercular Agents; Cycloserine; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Isoxazoles; Oxazolidinones; Pharmaceutical Preparations; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2020 |
Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Cycloserine; Depression; Female; HIV Infections; Humans; Incidence; Isoxazoles; Male; Middle Aged; Oxazolidinones; Peripheral Nervous System Diseases; Prospective Studies; Psychoses, Substance-Induced; Risk Factors; Tuberculosis, Multidrug-Resistant | 2021 |